NCT00561431View on ClinicalTrials.gov

High Dose CVVHDF Compared to Standard Dose CVVHDF

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Acute Renal Failure
Interventions
DEVICE

Standard dose of dialysis

Continuous Venovenous Hemodiafiltration (CVVHDF) effluent dose of 20 ml/kg/hr

DEVICE

High dose of dialysis

Continuous Venovenous Hemodiafiltration (CVVHDF) effluent rate 35 ml/kg/hr

Trial Locations (1)

35233

The University of Alabama at Birmingham, Birmingham

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Alabama at Birmingham

OTHER